Menu
Recruiting NCT07065682

Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia

Phase I Interventional BPH (Benign Prostatic Hyperplasia)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Aloevera + dutasteride, Dutasteride (0.5mg).
Who it may be relevant to
Registry conditions: BPH (Benign Prostatic Hyperplasia). Basic parameters: from 50 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Indonesia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study is a double blinded RCT with pre-post test design on the effect of combination of dutasteride and aloe vera, compared to dutasteride only, on uroflowmetry results, prostate volume, and VEGF serum level among patients with benign prostate hyperplasia. The treatment was given for 12 weeks

Interventions

  • Drug Aloevera + dutasteride
    Dutasteride 0,5 mg/day + Aloe Vera Extract 380 mg/day
  • Drug Dutasteride (0.5mg)
    Control

Primary outcome measures

  • Uroflowmetry result [Time frame: 12 weeks]
Secondary outcome measures (2)
  • Prostatic volume [Time frame: 12 weeks]
  • VEGF [Time frame: 12 weeks]

Eligibility criteria

Inclusion criteria

  • Diagnosed with BPH clinically or radiologically (prostate volume > 30 gram, Qmax <15 mL/s)
  • Willing to participate to the study

Exclusion criteria

  • Clinically or radiologically suspected of having prostatic cancer
  • Previous prostatic surgery
  • Patients with urinary retention
  • Patients with BPH complications: urinary tract infections, urolithiasis, or hydroneprhosis
  • Previously consumed alpha blocker or 5ARI in the last 6 months
  • Have consumed aloe vera extract routinely

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Single group
Masking
Quadruple blind
Primary purpose
Treatment

Study locations

Indonesia · 1 center
  • RSUD Karawang — Karawang

Publications

  • Nugroho E, Azhar A, Gunadi E. Relationship between Prostate Volume and International Prostate Symptom Score (IPSS) Degree of Tamed Prostate Enlargement on Transabdominal Ultrasonography (TAUS) and Transrectal Ultrasonography (TRUS) Examination. Biomed J Indones. 2021;1(7):112-7

Identifiers

NCT: NCT07065682 · 22010119510006

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗